212 related articles for article (PubMed ID: 21617193)
1. Polymorphism of the renalase gene in end-stage renal disease patients affected by hypertension.
Stec A; Semczuk A; Furmaga J; Ksiazek A; Buraczynska M
Nephrol Dial Transplant; 2012 Nov; 27(11):4162-6. PubMed ID: 21617193
[TBL] [Abstract][Full Text] [Related]
2. Rs10887800 renalase gene polymorphism is associated with an increased risk of coronary artery disease in hemodialyzed patients.
Stec A; Ksiazek A; Buraczynska M
Int Urol Nephrol; 2016 Jun; 48(6):871-6. PubMed ID: 27023477
[TBL] [Abstract][Full Text] [Related]
3. Renalase rs10887800 polymorphism is associated with severe pre-eclampsia in southeast Iranian women.
Teimoori B; Moradi-Shahrebabak M; Rezaei M; Mohammadpour-Gharehbagh A; Salimi S
J Cell Biochem; 2019 Mar; 120(3):3277-3285. PubMed ID: 30304564
[TBL] [Abstract][Full Text] [Related]
4. Renalase gene polymorphisms in patients with type 2 diabetes, hypertension and stroke.
Buraczynska M; Zukowski P; Buraczynska K; Mozul S; Ksiazek A
Neuromolecular Med; 2011 Dec; 13(4):321-7. PubMed ID: 21964580
[TBL] [Abstract][Full Text] [Related]
5. Rs10887800 renalase gene polymorphism influences the level of circulating renalase in patients undergoing hemodialysis but not in healthy controls.
Stec A
BMC Nephrol; 2017 Apr; 18(1):118. PubMed ID: 28372594
[TBL] [Abstract][Full Text] [Related]
6. Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population.
Zhao Q; Fan Z; He J; Chen S; Li H; Zhang P; Wang L; Hu D; Huang J; Qiang B; Gu D
J Mol Med (Berl); 2007 Aug; 85(8):877-85. PubMed ID: 17216203
[TBL] [Abstract][Full Text] [Related]
7. Renalase Gene rs2576178 Polymorphism in Hemodialysis Patients: Study in Bosnia and Herzegovina.
Kiseljakovic E; Mackic-Djurovic M; Hasic S; Beciragic A; Valjevac A; Alic L; Resic H
Med Arch; 2016 Feb; 70(1):31-4. PubMed ID: 26980928
[TBL] [Abstract][Full Text] [Related]
8. Renalase gene polymorphism is associated with increased blood pressure in preeclampsia.
Bagci B; Karakus S; Bagci G; Sancakdar E
Pregnancy Hypertens; 2016 Apr; 6(2):115-20. PubMed ID: 27155338
[TBL] [Abstract][Full Text] [Related]
9. Renalase gene polymorphism and epinephrine level in chronic kidney disease.
Rezk NA; Zidan HE; Elnaggar YA; Ghorab A
Appl Biochem Biotechnol; 2015 Feb; 175(4):2309-17. PubMed ID: 25484193
[TBL] [Abstract][Full Text] [Related]
10. Platelet GP IIIA polymorphism HPA-1 (PLA1/2) is associated with hypertension as the primary cause for end-stage renal disease in hemodialysis patients from Greece.
Chiras T; Papadakis ED; Katopodi A; Chatzianesti E; Fourtounas K; Papakonstantinou S; Theodoropoulos I; Dakouras A; Zerefos N; Valis D; Tzanatos-Exarchou H
In Vivo; 2009; 23(1):177-81. PubMed ID: 19368146
[TBL] [Abstract][Full Text] [Related]
11. Role of non-HLA genetic variants in end-stage renal disease.
Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
[TBL] [Abstract][Full Text] [Related]
12. Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with chronic kidney disease.
Elshamaa MF; Sabry S; Badr A; El-Ahmady M; Elghoroury EA; Thabet EH; Kandil D; Kamel S
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):487-92. PubMed ID: 21519233
[TBL] [Abstract][Full Text] [Related]
13. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease.
Buraczynska M; Ksiazek P; Zaluska W; Nowicka T; Ksiazek A
Nephrol Dial Transplant; 2004 Sep; 19(9):2302-6. PubMed ID: 15299097
[TBL] [Abstract][Full Text] [Related]
14. Complement receptor 1 gene polymorphism and cardiovascular disease in dialyzed end-stage renal disease patients.
Buraczynska M; Ksiazek P; Wacinski P; Zukowski P; Dragan M; Bednarek-Skublewska A
Hum Immunol; 2010 Sep; 71(9):878-82. PubMed ID: 20538029
[TBL] [Abstract][Full Text] [Related]
15. Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease.
Reiterová J; Merta M; Stekrová J; Cabartová Z; Cibulka R; Maixnerová D; Rysavá R; Ríhová Z; Tesar V; Motán J
Kidney Blood Press Res; 2006; 29(3):182-8. PubMed ID: 16943682
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis.
Buraczynska M; Jozwiak L; Ksiazek P; Borowicz E; Mierzicki P
Transl Res; 2007 Aug; 150(2):101-5. PubMed ID: 17656329
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Renalase gene rs2576178 polymorphism in patients with coronary artery disease.
Hu N; Wang J; Hu P; Li Z
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30181378
[TBL] [Abstract][Full Text] [Related]
18. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients.
Buraczynska M; Bednarek-Skublewska A; Buraczynska K; Ksiazek A
Cytokine; 2008 Dec; 44(3):361-5. PubMed ID: 19014891
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin and losartan may upregulate renalase activity in hypertension but not coronary artery diseases: The role of gene polymorphism.
Akbari H; Asadikaram G; Vakili S; Masoumi M
J Cell Biochem; 2019 Jun; 120(6):9159-9171. PubMed ID: 30548657
[TBL] [Abstract][Full Text] [Related]
20. Renalase deficiency in chronic kidney disease, and its contribution to hypertension and cardiovascular disease.
Desir GV
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):181-5. PubMed ID: 18277152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
